Drugs / Medicines Recalls and Alerts |
 |
FDA, Boston Scientific Recalls Flextome Cutting Balloon Systems
Date: 2/3/2006
Reason: The catheter shaft used to place the balloon in the artery may separate during withdrawal of the device from the patient. If that happens, the procedure may be prolonged, or more in-depth surgery may be required to remove the broken-off piece from the artery. Distribution: Nationwide.
Need Legal Help?
Does this recall or safety alert affect you or your family?
|
The Food and Drug Administration (FDA) released the following information:
Product: Flextome Cutting Balloon Device Monorail Delivery System
Use: The Flextome Cutting Balloon system is used to open blocked arteries or blood vessels. It consists of a surgical balloon with microsurgical blades attached to the sides. The balloon is inserted into the artery with a catheter, and then dilated. When the balloon expands, the microblades cut through fatty deposits, widening the blocked artery.
Recalling Firm: Boston Scientific Corporation 3574 Ruffin Road San Diego, California 92123-2597
Reason for Recall: The catheter shaft used to place the balloon in the artery may separate during withdrawal of the device from the patient. If that happens, the procedure may be prolonged, or more in-depth surgery may be required to remove the broken-off piece from the artery.
Public Contact: Abe Matthews Vice President of Regulatory Affairs Boston Scientific Corporation 3574 Ruffin Road San Diego, California 92123-2597 858-254-7885
FDA District: Los Angeles
FDA Comments: This product should no longer be used on patients and should be returned to Boston Scientific. This action does not affect patients who have already received treatment, because the problem occurs during the procedure.
Other Drugs / Medicines Recalls and Alerts of Interest
Date: 6/12/2008 Reason: Taking AZASAN® instead of SOLODYN® presents a health hazard and safety risk to patients
Distribution: Nationwide
Date: 6/12/2008 Reason: it contained a potentially harmful undeclared ingredient, hydroxyhomosildenafil
Distribution: Nationwide
Date: 6/12/2008 Reason: Oversized tablets may contain as much as two times the labeled level of active morphine sulfate
Distribution: Nationwide
Date: 6/12/2008 Reason: Limited lots of Atrium heparin-coated Hydraglide Thoracic Catheters were manufactured with heparin found to have been contaminated with oversulfated chondroitin sulfate (OSCS)
Distribution: Nationwide
Date: 6/12/2008 Reason: Limited lots of Carmeda-coated products were manufactured with heparin found to have been contaminated with oversulfated chondroitin sulfate (OSCS).
Distribution: Nationwide
Date: 6/16/2008 Reason: Oversized tablets may contain as much as two times the labeled level of active morphine sulfate
Distribution: Nationwide
|